𝔖 Bobbio Scriptorium
✦   LIBER   ✦

History of Wilson's disease: 1912 to 2000

✍ Scribed by John M. Walshe

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
190 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

There is a most unusual thing Known as the Kayser Fleischer ring. In fact it is so very rare Few doctors know when it is there. So whether brown or whether green It's very, very seldom seen. Had it been red, or even pink, Why then I really dare to think That most physicians would perchance See it with a perfunctory glance.

So let us deem it right and proper

To seek this little ring of copper.

πŸ“œ SIMILAR VOLUMES

Cannabis sativa and dystonia secondary t
Cannabis sativa and dystonia secondary to Wilson's disease
✍ M. Claudia Uribe Roca; Federico Micheli; Ricardo Viotti πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 56 KB

## Abstract A patient with generalized dystonia due to Wilson's disease obtained marked improvement in response to smoking cannabis. Β© 2004 Movement Disorder Society

Evaluation of the Unified Wilson's Disea
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease
✍ Barbara Leinweber; J. Carsten MΓΆller; Andre Scherag; Ulrike Reuner; Peter GΓΌnthe πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 1 views

## Abstract Wilson's disease (WD) is an inherited autosomal‐recessive disorder of copper metabolism characterized by a wide variety of neurological, hepatic, and psychiatric symptoms. The aim of the present study was the development and evaluation of a clinical rating scale, termed Unified Wilson's

Zinc therapy of Wilson's disease: Two vi
Zinc therapy of Wilson's disease: Two views
✍ George J. Brewer; I. Herbert Scheinberg πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 427 KB

After initial promotion of copper excretion with D-penicillamine, the effect of oral zinc sulphate (3 x 150 mg/day, loading dose; 3 x 100 mg/day, maintenance dose) in two children with clinically stable Wilson's disease was evaluated after completion of three years' treatment. The course, judged by